LL-37 stack pairing — what the research literature has examined
Overview of which research peptides LL-37 has been studied alongside in published preclinical research, and the rationale for those pairings in mechanism-level investigations.
LL-37 in multi-peptide research
Preclinical research involving LL-37 sometimes investigates it alongside other peptides — either to probe overlapping signalling pathways or to characterise additive versus synergistic effects in vitro. This page summarises the pairings that appear in the published literature at a citation level. It is not a recommendation, not a human-dosing protocol, and not a therapeutic stack.
A human cathelicidin antimicrobial peptide researched for broad-spectrum antimicrobial, immunomodulatory, and wound-healing properties.
Pairings that appear in preclinical studies
Tissue-repair-class peptides (e.g. BPC-157 and TB-500) appear together in published in-vitro and animal-model research investigating complementary cell-migration and angiogenesis pathways. Researchers studying LL-37 sometimes include such peer compounds as comparators or as pathway-overlap probes within the same experimental run.
Peptify supplies several of these compounds individually and, where the pairing rationale is well-established, in pre-blended research vials with a single Certificate of Analysis covering the combined formulation. Each constituent's identity and purity is HPLC-verified by Janoshik Analytical.
Pre-blended research vials at Peptify
Peptify currently offers four pre-blended multi-peptide research vials, each with a single Janoshik Certificate of Analysis confirming 99%+ HPLC purity for every constituent:
- GLOW Blend 70mg — GHK-Cu (50mg) + TB-500 (10mg) + BPC-157 (10mg)
- KLOW Blend 80mg — KPV + GHK-Cu + TB-500 + BPC-157
- BPC-157 + TB-500 Recovery Blend 20mg
- Selank + Semax Cognition Blend 20mg
A pre-blend supplies the combination as one lyophilised powder, one reconstitution, one COA — useful for researchers running fixed-ratio multi-peptide protocols where the ratio itself is part of the experimental design.
This content is provided for research and laboratory reference only. All Peptify
products are sold strictly for in-vitro research and are not intended for human or
animal consumption. Consult the Peptify compliance page for full regulatory details.
Buy LL-37 for research
99%+ HPLC-verified LL-37 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is LL-37?
LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. It is studied in the antimicrobial, immune-modulation, and epithelial-barrier research literature.
What is LL-37 researched for?
Published preclinical research has examined LL-37 in antimicrobial-pathway, immune-signalling, and epithelial-barrier studies. It is one of the most-studied endogenous host-defence peptides in the in-vitro literature.
What purity does Peptify LL-37 meet?
Peptify LL-37 is 99%+ HPLC-verified with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.